Ficalora Joins Patient Innovations Advisory Board

NEW YORK, July 30, 2019 /PRNewswire/ — Joseph R. Ficalora, President, Chief Executive Officer and a Director of New York Community Bancorp – the 25th largest bank holding company in the nation – has joined the Patient Innovations Advisory Board.

Under Mr. Ficalora’s leadership, the bank grew from a local savings bank to a regional banking powerhouse with 251 locations in five states.

Ken Greenberg, Patient Innovations Co-founder and President noted, “We are thrilled to have Joe Ficalora join our team. His business and financial acumen and desire for growth are a perfect fit and alignment with the PI mission.”

John M. Tabone, Chairman & CEO said, “It’s an honor and privilege to welcome Joe Ficalora to our Advisory Board. He represents an amazing addition to our fine team of healthcare leaders. Joe’s banking, business and growth skills – along with his strong commitment to community service – will help us steer Patient Innovations forward.”

Mr. Ficalora commented, “NYCB is a community bank committed to being a good neighbor. We’re here to serve our communities. The Patient Innovations OnTimeCare technology platform reduces endless waiting in doctors’ offices and helps make hospitals more efficient. This means greater access and a better patient experience for the communities we serve. Ultimately, this can slow the rising cost of healthcare. These are important goals that fit well with our mission to serve.”

See Mr. Ficalora’s bio here.

About Patient Innovations
Patient Innovations is converging technology, clinical insights and real-time provider and asset data to address the inefficiencies in patient access, healthcare delivery and compliance. Our interoperable RTLS platform manages content at scale and provides persisted datasets that drive optimal clinical workflows and insights that shape care decisions.

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/ficalora-joins-patient-innovations-advisory-board-300892702.html

SOURCE Patient Innovations

Staff

Recent Posts

OBI Pharma and TegMine Therapeutics Sign Exclusive Global License Agreement for Glycan-Targeting ADC

Successful Delivery of Commissioned ADC Candidate to Advance the Collaboration Between OBI and TegMine TAIPEI,…

3 seconds ago

ZYUS Life Sciences Announces LIFE Offering of a minimum of C$15 Million and maximum of C$16 Million of Units

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES SASKATOON,…

16 seconds ago

Mixie Technologies, Inc. (PHCG) Announces CES Picks Award Recognition for HoloTwin LLC

Recognition by TechRadar Pro at CES 2026 underscores the strategic rationale behind Mixie’s strategic investment…

22 seconds ago

HealthEquity Announces Fiscal Year 2027 Outlook Presentation at J.P. Morgan Healthcare Conference

DRAPER, Utah, Jan. 12, 2026 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the…

27 seconds ago

Achieve Life Sciences Confirms Promotion of Dr. Mark Rubinstein to Chief Medical Officer

Experienced medical executive advances to permanent role following successful leadership as Interim CMOSEATTLE and VANCOUVER,…

37 seconds ago

ACCENT DATA PRESENTED AT 2026 ASCO GASTROINTESTINAL CANCER SYMPOSIUM

HIGHLIGHTS Results from the Phase 2a ACCENT trial in pancreatic cancer have been presented at…

46 seconds ago